ask="2.40"
ask_size="2000"
average_daily_volume="51324"
bid="2.38"
bid_size="100"
book_value="0.43"
change="+0.05"
change_from_200_day_moving_average="0.09"
change_from_50_day_moving_average="0.16"
change_from_52_week_high="-1.15"
change_From_52_week_low="0.59"
change_in_percent="+2.09%"
close="2.44"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.34"
ebitda="-8.26M"
eps_estimate_current_year="-0.31"
eps_estimate_next_quarter="-0.06"
eps_estimate_next_year="-0.33"
ex_dividend_date="N/A"
float_shares="12379000"
high="2.48"
high_52_weeks="3.59"
last_trade_date="1/6/2017"
last_trade_price="2.44"
last_trade_size="100"
last_trade_time="4:02pm"
low="2.33"
low_52_weeks="1.85"
market_capitalization="32.64M"
moving_average_200_day="2.35"
moving_average_50_day="2.28"
name="Can-Fite Biopharma Ltd Sponsore"
notes="N/A"
one_year_target_price="5.00"
open="2.37"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+3.92%"
percent_change_from_50_day_moving_average="+7.10%"
percent_change_from_52_week_high="-32.03%"
percent_change_from_52_week_low="+31.89%"
previous_close="2.39"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.61"
price_per_sales="165.46"
revenue="193253.00"
shares_outstanding="13379000"
short_ratio="8.62"
stock_exchange="ASE"
symbol="CANF"
volume="52595"
weeks_range_52="1.85 - 3.59"
